MBS-306

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameMBS-306
Drug Alias NameMBS-306
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsAngiopoietin-2Vascular endothelial growth factor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A